Evidence map›Paper›PMID 33633290›Full record

ArticleScientific reports2021

Power law behaviour in the saturation regime of fatality curves of the COVID-19 pandemic.

Giovani L Vasconcelos, Antônio M S Macêdo, Gerson C Duarte-Filho, Arthur A Brum, Raydonal Ospina, Francisco A G Almeida

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Scale-free dynamics of COVID-19 in a Brazilian city.Applied mathematical modelling · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The distribution of COVID-19 mortality.Infectious Disease Modelling · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Giovani L VasconcelosDepartamento de Física, Universidade Federal do Paraná, 81531-990, Curitiba, Paraná, Brazil. giovani.vasconcelos@ufpr.br.
Antônio M S MacêdoDepartamento de Física, Universidade Federal de Pernambuco, 50670-901, Recife, Pernambuco, Brazil.
Gerson C Duarte-FilhoDepartamento de Física, Universidade Federal de Sergipe, 49100-000, São Cristóvão, Sergipe, Brazil.
Arthur A BrumDepartamento de Física, Universidade Federal de Pernambuco, 50670-901, Recife, Pernambuco, Brazil.
Raydonal OspinaDepartamento de Estatística, Universidade Federal de Pernambuco, 50740-540, Recife, Pernambuco, Brazil.
Francisco A G AlmeidaDepartamento de Física, Universidade Federal de Sergipe, 49100-000, São Cristóvão, Sergipe, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 167348/2018-3Conselho Nacional de Desenvolvimento Científico e Tecnológico 303772/2017-4Conselho Nacional de Desenvolvimento Científico e Tecnológico 305305/2019-0Conselho Nacional de Desenvolvimento Científico e Tecnológico 312612/2019-2
6 · The paper itself

Abstract

We apply a versatile growth model, whose growth rate is given by a generalised beta distribution, to describe the complex behaviour of the fatality curves of the COVID-19 disease for several countries in Europe and North America. We show that the COVID-19 epidemic curves not only may present a subexponential early growth but can also exhibit a similar subexponential (power-law) behaviour in the saturation regime. We argue that the power-law exponent of the latter regime, which measures how quickly the curve approaches the plateau, is directly related to control measures, in the sense that the less strict the control, the smaller the exponent and hence the slower the diseases progresses to its end. The power-law saturation uncovered here is an important result, because it signals to policymakers and health authorities that it is important to keep control measures for as long as possible, so as to avoid a slow, power-law ending of the disease. The slower the approach to the plateau, the longer the virus lingers on in the population, and the greater not only the final death toll but also the risk of a resurgence of infections.

Indexed as

AlgorithmsCOVID-19EuropeHumansNorth AmericaPandemicsSARS-CoV-2

Identifiers

PMID33633290
PMCPMC7907114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.